Literature DB >> 21294652

High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle.

Michela Vezzoli1, Patrizia Castellani, Gianfranca Corna, Alessandra Castiglioni, Lidia Bosurgi, Antonella Monno, Silvia Brunelli, Angelo A Manfredi, Anna Rubartelli, Patrizia Rovere-Querini.   

Abstract

High-mobility group box 1 (HMGB1), a damage-associated molecular pattern (DAMP) molecules, favors tissue regeneration via recruitment and activation of leukocytes and stem cells. Here we demonstrate, in a model of acute sterile muscle injury, that regeneration is accompanied by active reactive oxygen species (ROS) production counterbalanced and overcome by the generation of antioxidant moieties. Mitochondria are initially responsible for ROS formation. However, they undergo rapid disruption with almost complete disappearance. Twenty-four hours after injury, we observed a strong induction of MURF1 and atrogin-1 ubiquitin ligases, key signals in activation of the proteasome system and induction of muscle atrophy. At later time points, ROS generation is maintained by nonmitochondrial sources. The antioxidant response occurs in both regenerating fibers and leukocytes that express high levels of free thiols and antioxidant enzymes, such as superoxide dismutase 1 (SOD1) and thioredoxin. HMGB1, a protein thiol, weakly expressed in healthy muscles, increases during regeneration in parallel with the antioxidant response in both fibers and leukocytes. A reduced environment may be important to maintain HMGB1 bioactivity. Indeed, oxidation abrogates both muscle stem cell migration in response to HMGB1 and their ability to differentiate into myofibers in vitro. We propose that the early antioxidant response in regenerating muscle limits HMGB1 oxidation, thus allowing successful muscle regeneration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294652     DOI: 10.1089/ars.2010.3341

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  31 in total

Review 1.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

Review 2.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

Review 3.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 4.  Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling.

Authors:  Zsolt Radak; Zhongfu Zhao; Erika Koltai; Hideki Ohno; Mustafa Atalay
Journal:  Antioxid Redox Signal       Date:  2012-11-16       Impact factor: 8.401

Review 5.  Cellular mechanisms and signals that coordinate plasma membrane repair.

Authors:  Adam Horn; Jyoti K Jaiswal
Journal:  Cell Mol Life Sci       Date:  2018-07-26       Impact factor: 9.261

Review 6.  Cell death, clearance and immunity in the skeletal muscle.

Authors:  C Sciorati; E Rigamonti; A A Manfredi; P Rovere-Querini
Journal:  Cell Death Differ       Date:  2016-02-12       Impact factor: 15.828

Review 7.  Role of inflammatory cells in fibroblast activation.

Authors:  Justin Hartupee; Douglas L Mann
Journal:  J Mol Cell Cardiol       Date:  2015-11-20       Impact factor: 5.000

Review 8.  The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction.

Authors:  Daniel J Weber; Yohance M Allette; David S Wilkes; Fletcher A White
Journal:  Antioxid Redox Signal       Date:  2015-05-14       Impact factor: 8.401

9.  Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage.

Authors:  Elena Rigamonti; Thierry Touvier; Emilio Clementi; Angelo A Manfredi; Silvia Brunelli; Patrizia Rovere-Querini
Journal:  J Immunol       Date:  2013-01-18       Impact factor: 5.422

10.  Life after death: targeting high mobility group box 1 in emergent cancer therapies.

Authors:  Z Sheng Guo; Zuqiang Liu; David L Bartlett; Daolin Tang; Michael T Lotze
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.